NEW YORK (GenomeWeb News) – Luminex has completed the acquisition of molecular diagnostics firm GenturaDx for $50 million in cash plus potential additional consideration based on milestones and/or product revenue performance.

Luminex announced the deal earlier this week to acquire the Hayward, Calif.-based firm, which is developing a real-time PCR system, called the IDbox System, that employs single-use cassettes for molecular diagnostic applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.